fda import alert glp-1 semaglutide tirzepatide green list creates 'green list' of drug ingredients approved for entry in the U.S FDA launches "Green List" to

Originally developed to treat type 2 diabetes (T2D), these drugs have since delivered major advances in managing obesity and cardiovascular risk reduction

Off-label usage of GLP-1 weight loss drugs stacked with steroids for quick fat loss with minimal muscle wastage is a serious health concern

Over two percent of adult patients now take a GLP-1 drug to treat overweight or obesity, according to a FAIR Health white paper entitled, Obesity and GLP-1 Drugs: A Claims-Based Analysis

Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.

The channeling of GLP-1 medicines via telehealth has come under criticism, most recently in the context of the Hims & Hers commercial that aired during the Superbowl LIX promoting the companys compounded therapy

This formula is paired with Chicory Inulin, a well-known prebiotic fiber that helps nourish beneficial gut bacteria, creating an optimal environment for gut and metabolic function